Art

J-GLOBAL ID：202102286653895968   Reference number：21A0599343

免疫再構築症候群/irAEの学び方・診方 肺がん治療におけるirAEの病態と対処法

Author (2)： TANAKA TOORU (日本医大 大学院医学研究科 呼吸器内科学分野) ,  KUBOTA KAORU (日本医大 大学院医学研究科 呼吸器内科学分野)
Material： Monthly Book Derma.  (MB Derma)
Issue： 305  Page： 48-54  Publication year： Feb. 15, 2021 
JST Material Number： L3871A  ISSN： 1343-0831  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *immune checkpoint inhibitor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0599343&from=J-GLOBAL&jstjournalNo=L3871A") }}

JST classification (1)： Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (13)：

• Postow MA, Sidlow R, Hellmann MD : Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med, 378 : 158-168, 2018.
• Sueki H, Mizukawa Y, Aoyama Y : Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients. J Dermatol, 45 :3-9, 2018.
• Toi Y, Sugawara S, Sugisaka J, et al : Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced NonSmall Cell Lung Cancer. JAMA Oncol, 5 :376-383, 2019.
• Osorio JC, Ni A, Chaft JE, et al : Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer. Ann Oncol, 28 :583-589, 2017.
• Diehl A, Yarchoan M, Hopkins A, et al : Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors. Oncotarget, 8 :114268-114280, 2017.

Terms in the title (7)： 免疫再構築症候群 ,  irAE ,  診方 ,  肺がん ,  治療 ,  病態 ,  対処